The Indian market is expected to open higher on Wednesday tracking positive trend seen in other Asian markets.
Here is a list of top ten stocks that are likely to be in focus today:
Wipro Ltd: The board of directors of India’s third largest software exporter WiproBSE 3.18 % will consider a proposal to buy back shares of the company on April 20, the day the company announces its March quarter results.
JP Associates Ltd: Infrastructure firm JP Associates has pulled out of the project to set up an electronic chip plant that entailed an investment of about Rs 34,000 crore.
Bajaj Corp: FMCG firm Bajaj CorpBSE -4.93 % reported a marginal decline in standalone net profit at Rs 54.02 crore for the fourth quarter ended March 31.
Agriculture & cyclical stocks will be in focus after the weather office has forecast surplus, well-distributed monsoon rainfall this year after two consecutive droughts.
Nalco: The state-owned aluminium maker Nalco is considering setting up a 5-lakh tonne per annum aluminium plant in Iran through a joint venture (JV).
GAIL India: Two Japanese consortiums have bid for state-owned gas utility GAIL IndiaBSE 0.41 % Ltd’s USD 7 billion tender for hiring nine newly built ships for ferrying LNG from the US.
South India Bank: South Indian Bank, the stagnating regional lender, is now going back to its core strength, which is retail, and plans to shake up business strategy aiming to more than double balance sheet size as well as profit by 2020.
RIL: The Mukesh Ambani-promoted Reliance IndustriesBSE 0.85 % Ltd ( RILBSE 0.85 %) on Tuesday floated an Expression of Interest (EoI) to develop its oil and gas blocks, including some of the discoveries in the KG-D6 block off the coast of Andhra Pradesh, said a media report.
Tata Steel: Tata SteelBSE 1.43 % UK Ltd’s signing of an agreement to sell its European long products business to UK-based investment firm Greybull Capital is credit positive for its parent, Tata Steel, Moody’s Investor Service said.
Shilpa Medicare: The company has received good manufacturing practice compliance certificate for two API sites from Pharmaceuticals and Medical Devices Agency, Japan.